| CPC C07D 471/04 (2013.01) [A61P 35/00 (2018.01); C07D 487/04 (2013.01)] | 17 Claims |
|
1. A compound represented by formula (III) or a pharmaceutically acceptable salt thereof,
![]() wherein,
T, T2 and T3 are each independently selected from N, and CH;
R1 is selected from H, C1-3 alkyl, tetrahydropyranyl, piperidinyl,
![]() wherein the C1-3 alkyl, tetrahydropyranyl, piperidinyl,
![]() are optionally substituted with 1, 2 or 3 Ra, and further wherein
is used to denote a point of attachment;R2 and R3 are each independently selected from H, F, Cl, Br, I, OH, and NH2;
R4 is selected from H, C1-3 alkyl, C1-3 alkoxy, C3-5 cycloalkyl, —CH2-1,3-dioxolanyl, and pyrrolidinyl, wherein the C1-3 alkyl, C1-3 alkoxy, C3-5 cycloalkyl, —CH2-1,3-dioxolanyl, and pyrrolidinyl are optionally substituted with 1, 2 or 3 Rb;
L is selected from —N(R5)C(═O)—, —N(R5)S(═O)2—, —N(R5)C(═O)N(R6)—, and —NR5—;
R5 and R6 are each independently selected from H, and C1-3 alkyl;
ring A is selected from phenyl, and pyridyl;
ring B is selected from cyclopropyl, morpholinyl, piperazinyl, tetrahydropyranyl, pyrazolyl, imidazolyl, and triazolyl;
Ra and Rb are each independently selected from H, F, Cl, Br, I, OH, NH2, CN, CH3, N(CH3)2, —S(═O)2CH3, and benzyl.
|